CorMedix Inc

NASDAQ:CRMD   3:59:50 PM EDT
3.38
-0.11 (-3.15%)
Earnings Announcements

Cormedix Reports Q4 Loss Per Share Of $0.20

Published: 03/29/2022 20:25 GMT
CorMedix Inc (CRMD) - Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Q4 Loss per Share $0.20.
Cash and Short-term Investments, Excluding Restricted Cash, at December 31, 2021 Amounted to $65.5 Million.
Revenue is expected to be $0.03 Million
Adjusted EPS is expected to be -$0.21

Next Quarter Revenue Guidance is expected to be $0.03 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.